Patient case: HIV/AIDS
A 32-year-old man presents to the clinic with a three-month history of unintentional weight loss, chronic diarrhea, night sweats, and persistent fatigue. He also reports recurrent oral ulcers and a nonproductive cough that has worsened over the past two weeks. He has no significant past medical history but admits to multiple unprotected sexual encounters in the past.
On examination, he appears thin and fatigued. His temperature is 38.2°C (100.8°F), and his heart rate is 98 bpm. He has oral thrush and generalized lymphadenopathy. Chest auscultation reveals mild bilateral crackles. Laboratory tests show a low CD4+ count of 120 cells/µL, and an HIV-1/2 antibody test returns positive. A sputum test is positive for Pneumocystis jirovecii, confirming Pneumocystis pneumonia (PCP), an opportunistic infection associated with advanced HIV/AIDS.
The patient is diagnosed with AIDS and started on antiretroviral therapy (ART) along with trimethoprim-sulfamethoxazole for PCP treatment and prophylaxis. Nutritional support and counseling on medication adherence are also provided. Over the following months, his condition stabilizes, and his CD4+ count begins to recover with consistent ART use.
a) Tuberculosis
b) HIV/AIDS with opportunistic infection
c) Chronic viral hepatitis
d) Lymphoma
a) Pneumocystis jirovecii pneumonia (PCP)
b) Bacterial pneumonia
c) Influenza
d) Fungal sinusitis
a) Acyclovir
b) Trimethoprim-sulfamethoxazole (TMP-SMX)
c) Azithromycin
d) Rifampin
a) Symptomatic treatment only
b) Delaying treatment until symptoms worsen
c) Immediate initiation of antiretroviral therapy (ART)
d) Monthly antibiotic therapy instead of ART
Answers
1. Answer: b) HIV/AIDS with opportunistic infection
The combination of weight loss, chronic diarrhea, oral thrush, and a low CD4+ count strongly suggests AIDS with opportunistic infections.
2. Answer: a) Pneumocystis jirovecii pneumonia (PCP)
PCP is a common opportunistic infection in patients with AIDS, typically presenting with a dry cough, dyspnea, and fever, especially when CD4+ counts are below 200 cells/µL.
3. Answer: b) Trimethoprim-sulfamethoxazole (TMP-SMX)
TMP-SMX is the first-line treatment for PCP and also serves as prophylaxis in patients with low CD4+ counts to prevent future infections.
4. Answer: c) Immediate initiation of antiretroviral therapy (ART)
ART should be started as soon as possible to suppress viral replication, improve immune function, and prevent further opportunistic infections.
